Evolvere Biosciences Analysis: $500K Raised
What is Evolvere Biosciences?
Evolvere Biosciences develops innovative immunology therapies to meet unmet medical needs.
Founded
2021
Company Stage
Pre-Seed
YC Batch
S24
Product Features & Capabilities
- next-generation antibiotics, precision targeting of pathogenic bacteria, combating antimicrobial resistance, rapid generation of antibacterials, dual revenue from therapeutic assets and licensed AI tools
How much Evolvere Biosciences raised
Pre-Seed - $500,000
September 25, 2024Lead Investor: Y Combinator
Who are the founders of Evolvere Biosciences
Investors
- Cleo Capital
- Y Combinator
- BioEscalator
- Saïd Business School
